92 related articles for article (PubMed ID: 21592863)
1. The role of interferon alpha in initiation of type I diabetes in the NOD mouse.
Li Q; McDevitt HO
Clin Immunol; 2011 Jul; 140(1):3-7. PubMed ID: 21592863
[TBL] [Abstract][Full Text] [Related]
2. The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner.
Stock AJ; Gonzalez Paredes P; de Almeida LP; Kosanke SD; Chetlur S; Budde H; Wakenight P; Zwingman TA; Rosen ABI; Allenspach EJ; Millen KJ; Buckner JH; Rawlings DJ; Gorman JA
Front Immunol; 2024; 15():1349601. PubMed ID: 38487540
[TBL] [Abstract][Full Text] [Related]
3. The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner.
Stock AJ; Gonzalez-Paredes P; Previato de Almeida L; Kosanke SD; Chetlur S; Budde H; Wakenight P; Zwingman TA; Rosen AB; Allenspach E; Millen KJ; Buckner JH; Rawlings DJ; Gorman JA
bioRxiv; 2024 Jan; ():. PubMed ID: 38328221
[TBL] [Abstract][Full Text] [Related]
4. Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes.
Jung S; Ben Nasr M; Bahmani B; Usuelli V; Zhao J; Sabiu G; Seelam AJ; Naini SM; Balasubramanian HB; Park Y; Li X; Khalefa SA; Kasinath V; Williams MD; Rachid O; Haik Y; Tsokos GC; Wasserfall CH; Atkinson MA; Bromberg JS; Tao W; Fiorina P; Abdi R
Adv Mater; 2023 Oct; 35(40):e2300812. PubMed ID: 37357903
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of immune cell responses in the multiple low-dose streptozotocin mouse model of type 1 diabetes.
Luo Z; Soläng C; Mejia-Cordova M; Thorvaldson L; Blixt M; Sandler S; Singh K
FASEB Bioadv; 2019 Sep; 1(9):538-549. PubMed ID: 32123849
[TBL] [Abstract][Full Text] [Related]
6. An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes.
Asadi F; Gunawardana SC; Dolle RE; Piston DW
JCI Insight; 2024 Jan; 9(2):. PubMed ID: 38258903
[TBL] [Abstract][Full Text] [Related]
7. Gα
Fenske RJ; Wienkes HN; Peter DC; Schaid MD; Hurley LD; Pennati A; Galipeau J; Kimple ME
J Endocr Soc; 2024 May; 8(7):bvae100. PubMed ID: 38831864
[TBL] [Abstract][Full Text] [Related]
8. B-1 B Cell-Derived Natural Antibodies against N-Acetyl-d-Glucosamine Suppress Autoimmune Diabetes Pathogenesis.
New JS; Dizon BLP; King RG; Greenspan NS; Kearney JF
J Immunol; 2023 Nov; 211(9):1320-1331. PubMed ID: 37747293
[TBL] [Abstract][Full Text] [Related]
9. A Targeted Deep Sequencing Method to Quantify Endogenous Retrovirus Gag Sequence Variants and Open Reading Frames Expressed in Nonobese Diabetic Mice.
Dai YD; Du W; Wang Y; Hu WY
J Immunol; 2024 May; ():. PubMed ID: 38738929
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes.
Diana J; Simoni Y; Furio L; Beaudoin L; Agerberth B; Barrat F; Lehuen A
Nat Med; 2013 Jan; 19(1):65-73. PubMed ID: 23242473
[TBL] [Abstract][Full Text] [Related]
11. The kinetics of plasmacytoid dendritic cell accumulation in the pancreas of the NOD mouse during the early phases of insulitis.
Welzen-Coppens JM; van Helden-Meeuwsen CG; Leenen PJ; Drexhage HA; Versnel MA
PLoS One; 2013; 8(1):e55071. PubMed ID: 23372814
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in type I interferon signaling prevents the early interferon-induced gene signature in pancreatic islets but not type 1 diabetes in NOD mice.
Quah HS; Miranda-Hernandez S; Khoo A; Harding A; Fynch S; Elkerbout L; Brodnicki TC; Baxter AG; Kay TW; Thomas HE; Graham KL
Diabetes; 2014 Mar; 63(3):1032-40. PubMed ID: 24353186
[TBL] [Abstract][Full Text] [Related]
13. Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse.
Carrero JA; Calderon B; Towfic F; Artyomov MN; Unanue ER
PLoS One; 2013; 8(3):e59701. PubMed ID: 23555752
[TBL] [Abstract][Full Text] [Related]
14. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.
Ferris ST; Carrero JA; Mohan JF; Calderon B; Murphy KM; Unanue ER
Immunity; 2014 Oct; 41(4):657-69. PubMed ID: 25367577
[TBL] [Abstract][Full Text] [Related]
15. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes.
Ferreira RC; Guo H; Coulson RM; Smyth DJ; Pekalski ML; Burren OS; Cutler AJ; Doecke JD; Flint S; McKinney EF; Lyons PA; Smith KG; Achenbach P; Beyerlein A; Dunger DB; Clayton DG; Wicker LS; Todd JA; Bonifacio E; Wallace C; Ziegler AG
Diabetes; 2014 Jul; 63(7):2538-50. PubMed ID: 24561305
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice.
Syed F; Ballew O; Lee CC; Rana J; Krishnan P; Castela A; Weaver SA; Chalasani NS; Thomaidou SF; Demine S; Chang G; Coomans de Brachène A; Alvelos MI; Marselli L; Orr K; Felton JL; Liu J; Marchetti P; Zaldumbide A; Scheuner D; Eizirik DL; Evans-Molina C
bioRxiv; 2024 May; ():. PubMed ID: 38766166
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndrome.
Zhou J; Zhang X; Yu Q
Biochim Biophys Acta Mol Basis Dis; 2022 Feb; 1868(2):166302. PubMed ID: 34780913
[TBL] [Abstract][Full Text] [Related]
18. Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes.
Badal D; Dayal D; Singh G; Sachdeva N
Sci Rep; 2020 Jun; 10(1):8896. PubMed ID: 32483133
[TBL] [Abstract][Full Text] [Related]
19. IL-21 regulates SOCS1 expression in autoreactive CD8
Sutherland APR; Graham KL; Papadimitriou M; Jhala G; Trivedi P; Catterall T; Fynch S; Kay TWH; Thomas HE
Sci Rep; 2019 Oct; 9(1):15302. PubMed ID: 31653894
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
